Non-Surgical Treatment for Adenomyosis
For symptomatic adenomyosis, start with a levonorgestrel-releasing intrauterine device (progestin IUD) as first-line therapy, which provides superior symptom control compared to combined oral contraceptives and addresses both bleeding and pain. 1
Medical Management Algorithm
First-Line Hormonal Therapy
Progestin IUD (Levonorgestrel-releasing IUD):
- Most effective first-line option for bleeding and pain control
- Superior to combined oral contraceptives in randomized controlled trials 1
- Benefits include: local mechanism of action, minimal systemic hormone exposure, long duration (up to 5 years), and user independence
- Does NOT address bulk symptoms (uterine enlargement, pressure)
Alternative First-Line Options:
- Combined oral contraceptives - effective for bleeding and pain, though less effective than progestin IUD 1
- GnRH antagonist combinations - pooled analysis of 2 RCTs shows effectiveness for heavy menstrual bleeding even with concomitant adenomyosis 1
Non-Hormonal Adjuncts
- NSAIDs - for pain control and bleeding reduction 1
- Tranexamic acid - nonhormonal option specifically for bleeding symptoms 1
Minimally Invasive Procedural Options (When Medical Therapy Fails)
Uterine Artery Embolization (UAE)
Use UAE when:
- Medical management fails
- Patient desires uterus preservation
- Not actively seeking pregnancy
Evidence for UAE:
- Meta-analysis shows 94% short-term (<12 months) and 85% long-term (>12 months) symptom improvement 1
- 7-18% eventually require hysterectomy for persistent symptoms 1, 2
- Up to 7-year follow-up data shows sustained quality of life improvement 1, 2
- Symptom control ranges 73-88% in recent studies with median follow-up 24-65 months 2
Important Caveats:
- Limited fertility data - counsel patients accordingly 1
- More effective when fibroids predominate over pure adenomyosis 1
- Ongoing QUESTA trial comparing UAE to hysterectomy outcomes 1
Critical Treatment Limitations
What Medical Therapy CANNOT Do:
- Hormonal treatments (progestin IUD, oral contraceptives, GnRH antagonists) will NOT treat bulk symptoms like uterine enlargement or pressure effects 1
- If bulk symptoms are the primary complaint, consider UAE or surgical options
Fertility Considerations:
- For women desiring pregnancy, comprehensive fertility data after UAE is lacking 1
- GnRH analogues may be used before fertility treatments to improve pregnancy chances 3
- Successful pregnancies reported after UAE but with limited data 1
Treatment Selection Framework
- Bleeding and/or pain WITHOUT bulk symptoms → Progestin IUD first-line
- Bleeding and/or pain WITH bulk symptoms → Consider UAE after failed medical therapy
- Failed medical therapy + desire for uterus preservation → UAE (expect 85-94% symptom improvement)
- Seeking fertility → GnRH analogues before fertility treatment; avoid UAE as first choice
Common Pitfalls to Avoid
- Don't use myomectomy alone - adenomyosis is diffuse and unlikely to be effectively addressed by focal excision 1
- Don't expect hormonal therapy to shrink the uterus - these medications control symptoms but don't address bulk
- Don't overlook coexisting conditions - adenomyosis frequently coexists with fibroids and endometriosis, which may alter treatment approach 2
- Don't promise cure with medical therapy - no current drug can cure adenomyosis; treatment is symptom management 4, 3
The evidence strongly supports a stepwise approach: medical management first (progestin IUD preferred), then UAE for failures desiring uterus preservation, with hysterectomy reserved for definitive treatment when fertility is not desired and other options have failed.